Contains fulltext : 136110.pdf (publisher's version ) (Open Access)In this double-blind randomized placebo-controlled trial involving 30 healthy male volunteers we investigated the acute effects of iron loading (single dose of 1.25 mg/kg iron sucrose) and iron chelation therapy (single dose of 30 mg/kg deferasirox) on iron parameters, oxidative stress, the innate immune response, and subclinical organ injury during experimental human endotoxemia. The administration of iron sucrose induced a profound increase in plasma malondialdehyde 1 h after administration (433+/-37% of baseline; P<0.0001), but did not potentiate the endotoxemia-induced increase in malondialdehyde, as was seen 3 h after endotoxin administration in the pl...
Contains fulltext : 79604.pdf (publisher's version ) (Closed access)The correct se...
Atherosclerotic heart disease has claimed the lives of millions of people each year in the Western w...
Background. Iron sucrose (Fe-S) and low-molecular-weight iron dextran (Fe-D) have been used successf...
In this double-blind randomized placebo-controlled trial involving 30 healthy male volunteers we inv...
This chapter intends to contribute to a deeper understanding of the main pathways playing a role in ...
Contains fulltext : 50778.pdf (publisher's version ) (Closed access)BACKGROUND: Ch...
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human...
Contains fulltext : 49413.pdf (publisher's version ) (Closed access)Nontransferrin...
It is widely assumed that, at matched transfusional iron-loading rates, responses to chelation thera...
Parenteral iron therapy exacerbates experimental sepsis.BackgroundCatalytic iron can potentiate syst...
Contains fulltext : 48502.pdf (publisher's version ) (Closed access)Hepatic peptid...
Objectives: It is widely assumed that, at matched transfusional iron-loading rates, responses to che...
Background: The importance of hemoproteins for life lies largely in their iron-mediated chemical pro...
Objectives: It is widely assumed that, at matched transfusional iron- loading rates, responses to ch...
Randomized phase II trial of deferasirox (Exjade®, ICL670), a once-daily, orally-administered iron c...
Contains fulltext : 79604.pdf (publisher's version ) (Closed access)The correct se...
Atherosclerotic heart disease has claimed the lives of millions of people each year in the Western w...
Background. Iron sucrose (Fe-S) and low-molecular-weight iron dextran (Fe-D) have been used successf...
In this double-blind randomized placebo-controlled trial involving 30 healthy male volunteers we inv...
This chapter intends to contribute to a deeper understanding of the main pathways playing a role in ...
Contains fulltext : 50778.pdf (publisher's version ) (Closed access)BACKGROUND: Ch...
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human...
Contains fulltext : 49413.pdf (publisher's version ) (Closed access)Nontransferrin...
It is widely assumed that, at matched transfusional iron-loading rates, responses to chelation thera...
Parenteral iron therapy exacerbates experimental sepsis.BackgroundCatalytic iron can potentiate syst...
Contains fulltext : 48502.pdf (publisher's version ) (Closed access)Hepatic peptid...
Objectives: It is widely assumed that, at matched transfusional iron-loading rates, responses to che...
Background: The importance of hemoproteins for life lies largely in their iron-mediated chemical pro...
Objectives: It is widely assumed that, at matched transfusional iron- loading rates, responses to ch...
Randomized phase II trial of deferasirox (Exjade®, ICL670), a once-daily, orally-administered iron c...
Contains fulltext : 79604.pdf (publisher's version ) (Closed access)The correct se...
Atherosclerotic heart disease has claimed the lives of millions of people each year in the Western w...
Background. Iron sucrose (Fe-S) and low-molecular-weight iron dextran (Fe-D) have been used successf...